Relationship Between Health-Related Quality of Life and Work Productivity in Patients With Ulcerative Colitis in the Tofacitinib OCTAVE Phase 3 Induction and Maintenance Studies

被引:0
作者
Targownik, Laura [1 ]
Dubinsky, Marla C. [2 ]
Steinwurz, Flavio [3 ]
Bushmakin, Andrew G. [4 ]
Cappelleri, Joseph C. [4 ]
Tai, Elaine [5 ]
Gardiner, Sean [6 ]
Hur, Peter [6 ]
Panes, Julian [7 ]
机构
[1] Univ Toronto, Mt Sinai Hosp, Toronto, ON, Canada
[2] Icahn Sch Med Mt Sinai, Susan & Leonard Feinstein IBD Ctr, New York, NY 10029 USA
[3] Hosp Israelita Albert Einstein, Unit Inflammatory Bowel Dis, Sao Paulo, SP, Brazil
[4] Pfizer Inc, Groton, CT 06340 USA
[5] Pfizer Canada, Kirkland, PQ, Canada
[6] Pfizer Inc, New York, NY USA
[7] Hosp Clin Barcelona, IDIBAPS, CIBERehd, Barcelona, Spain
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
S1040
引用
收藏
页码:S753 / S754
页数:2
相关论文
共 50 条
[11]   Impact of MMX® Mesalamine on Improvement and Maintenance of Health-Related Quality of Life in Patients with Ulcerative Colitis [J].
Hodgkins, Paul ;
Yen, Linnette ;
Yarlas, Aaron ;
Karlstadt, Robyn ;
Solomon, Dory ;
Kane, Sunanda .
INFLAMMATORY BOWEL DISEASES, 2013, 19 (02) :386-396
[12]   Health-related quality of life, work productivity, and persisting challenges in treated ulcerative colitis patients: a Japanese National Health and Wellness Survey [J].
Hiraoka, Sakiko ;
Huang, Zhezhou ;
Qin, Fei ;
Arokianathan, Fatima Megala Nathan ;
Dave, Kiran ;
Shah, Shweta ;
Kim, Hyunchung .
INTESTINAL RESEARCH, 2025,
[13]   Maintenance of quality of life improvement in a phase 3 study of tofacitinib for patients with moderately to severely active ulcerative colitis [J].
Panes, J. ;
Rubin, D. T. ;
Vermeire, S. ;
Lindsay, J. O. ;
Sands, B. E. .
JOURNAL OF CROHNS & COLITIS, 2017, 11 :S315-S317
[14]   Assessment of Health-Related Quality of Life and Patient-Reported Outcomes With Tofacitinib Treatment Stratified by Age in Patients From the OCTAVE Ulcerative Colitis Clinical Program [J].
Dubinsky, Marla C. ;
Biedermann, Luc ;
Hart, Ailsa ;
Panes, Julian ;
Rubin, David T. ;
Fellmann, Marc ;
Gardiner, Sean ;
Paulissen, Jerome ;
Almadi, Majid A. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10) :S741-S742
[15]   MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS [J].
Panes, J. ;
Rubin, D. T. ;
Vermeire, S. ;
Lindsay, J. O. ;
Sands, B. E. ;
Su, C. ;
Friedman, G. ;
Zhang, H. ;
Kayhan, C. ;
Manuchehri, A. ;
Healey, P. .
GUT, 2017, 66 :A121-A122
[16]   MAINTENANCE OF QUALITY OF LIFE IMPROVEMENT IN A PHASE 3 STUDY OF TOFACITINIB FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS [J].
Panes, Julian ;
Rubin, David T. ;
Vermeire, Severine ;
Lindsay, James O. ;
Sands, Bruce E. ;
Su, Chinyu ;
Friedman, Gary ;
Zhang, Haiying ;
Kayhan, Cem ;
Manuchehri, Alireza ;
Healey, Paul J. .
GASTROENTEROLOGY, 2017, 152 (05) :S601-S602
[17]   Guselkumab maintenance treatment improves health-related quality of life in patients with moderately to severely active Ulcerative Colitis: Phase 3 QUASAR maintenance study [J].
Bressler, B. ;
Peyrin-Biroulet, L. ;
Afif, W. ;
Samaan, M. A. ;
Wei, S. C. ;
Yarandi, S. ;
Germinaro, M. ;
Mistry, P. ;
Han, C. ;
Allegretti, J. R. ;
Lichtenstein, G. R. .
JOURNAL OF CROHNS & COLITIS, 2025, 19 :i2133-i2135
[18]   ANALYSIS OF HEMATOLOGICAL CHANGES IN TOFACITINIB-TREATED PATIENTS WITH ULCERATIVE COLITIS ACROSS PHASE 3 INDUCTION AND MAINTENANCE STUDIES [J].
Lichtenstein, Gary R. ;
Moore, Gregory T. ;
Soonasra, Arif ;
Nduaka, Chudy I. ;
Kwok, Kenneth ;
Wang, Lisy ;
Lawendy, Nervin ;
Chan, Gary ;
Su, Chinyu ;
Loftus, Edward V. .
GASTROENTEROLOGY, 2019, 156 (06) :S1111-S1111
[19]   Analysis of haematological changes in tofacitinib-treated patients with ulcerative colitis across Phase 3 induction and maintenance studies [J].
Lichtenstein, G. R. ;
Moore, G. T. ;
Soonasra, A. ;
Nduaka, C. I. ;
Kwok, K. ;
Wang, L. ;
Lawendy, N. ;
Chan, G. ;
Su, C. ;
Loftus, E. V., Jr. .
JOURNAL OF CROHNS & COLITIS, 2019, 13 :S351-S352
[20]   Tofacitinib in Ulcerative Colitis: The Relationship Between OCTAVE Induction Week 8 Symptomatic Remission and OCTAVE Sustain Week 52 Remission [J].
Desreumaux, Pierre ;
Akyuz, Filiz ;
Ha, Christina ;
Bouzidi, Amira ;
Tamzali, Amel ;
Gardiner, Sean ;
Wu, Joseph ;
Paulissen, Jerome ;
Vuitton, Lucine ;
Regueiro, Miguel .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10) :S913-S914